Kamada (KMDA) Cash from Operations (2012 - 2026)
Kamada (KMDA) reported Cash from Operations of 291000.0 for Q1 2026, up 43.27% on a YoY basis from 203106.12 in Q1 2025, and down 103.85% quarter-over-quarter from 7566000.0 in Q4 2025.
Kamada (KMDA) Cash from Operations (2012 - 2026) Analysis & Trends
Kamada has reported Cash from Operations for 15 years, with the latest figure at 291000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 43.27% year-over-year to 291000.0; the trailing twelve-month figure through Mar 2026 stood at 25712000.0 (down 44.18% YoY), and the FY2025 full-year result was 25490000.0, down 46.44% from the prior year.
- Cash from Operations for Q1 2026 stood at 291000.0, down from 7566000.0 in the prior quarter.
- The five-year high for Cash from Operations was 22213000.0 in Q3 2024, with the low at 513000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 5764904.88 across 5 years, with a median of 5465000.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 90525.93% — and 2025, when it sank 150.29%.
- Kamada's Cash from Operations stood at 6742.0 in 2022, then surged by 90525.93% to 6110000.0 in 2023, then soared by 70.18% to 10398000.0 in 2024, then slipped by 27.24% to 7566000.0 in 2025, then slumped by 103.85% to 291000.0 in 2026.
- The last three Cash from Operations figures came in at 291000.0 (Q1 2026), 7566000.0 (Q4 2025), and 10416000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -291,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -291,000.00 |
| Mar 31, 2026 | -291,000.00 |
| Dec 31, 2025 | 7.57 Mn |
| Dec 31, 2025 | 7.57 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Sep 30, 2025 | 10.42 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Jun 30, 2025 | 8.02 Mn |
| Mar 31, 2025 | -513,000.00 |
| Mar 31, 2025 | -513,000.00 |
| Dec 31, 2024 | 10.40 Mn |
| Dec 31, 2024 | 10.40 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Sep 30, 2024 | 22.21 Mn |
| Jun 30, 2024 | 13.96 Mn |
| Jun 30, 2024 | 13.96 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 6.11 Mn |
| Dec 31, 2023 | 6.11 Mn |